EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Longitudinal Phenotypic Trajectories in GNAO1 ‐Related Disorders: Defining Disease Progression and Clinical Profiles

Jana Domínguez-Carral iD, Ana María Domínguez Cobo, Sol Balsells, Anna Aguilar-Ros, Chu-Ting Chang, William G Ludlam, Kathryn Yang iD, Katerina Bernardi iD, Micaela Chinigioli, Ainara Salazar-Villacorta iD, Veronica Di Pisa, Nuria Lamagrande-Casanova und 41 weitere

Annals of Neurology · 2026

DOI: 10.1002/ana.78213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Neurology, 2026. Verfasst von Jana Domínguez-Carral und 52 weiteren Autor:innen. Beteiligte Einrichtung: Epilepsy Unit, Department of Child Neurology, Coordinating member of the ERN EpiCARE, Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona,…. Hauptthemen laut MEDLINE: GTP-Binding Protein alpha Subunits, Gi-Go, Epilepsy, Movement Disorders, Neurodevelopmental Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Pathogenic variants in GNAO1 cause a spectrum of epilepsy, movement disorders, and developmental impairment. Clinical heterogeneity complicates prognosis and therapeutic development. We present the first longitudinal natural history study of GNAO1 ‐related disorders ( GNAO1 ‐RD) to delineate phenotypic trajectories.

Methods

Sixty‐six individuals with GNAO1 ‐RD were included in a cross‐sectional analysis. Of these, 21 were enrolled in a prospective natural history arm (March 2021–December 2024), undergoing annual standardized evaluations with validated clinical scales to monitor phenotypic progression.

Results

Our cohort exhibited broad phenotypic and severity variability. GNAO1 ‐RD severity scores ranged from 0.5 to 13. Neurodevelopmental impairment varied: 45.5% lacked head control, whereas 22.7% achieved independent walking; and 65% had no expressive language. Movement disorders were nearly universal (95.5%), with dyskinetic crises in 54.5%. Epilepsy affected 51.5%, with different seizure types. Individuals carrying recurrent variants showed consistent phenotypes and severity, supporting a genotype–phenotype correlation reinforced by molecular functional data. Molecular functional analysis for 20 of 31 missense variants correlated with severity scores. Longitudinal data from 21 patients in the natural history cohort showed overall stability or mild improvement across most functional domains. No significant deterioration was observed in global severity, motor function, cognition, or quality of life. However, severe patients experienced progressive worsening of movement disorder.

Interpretation

This largest GNAO1 ‐RD cohort and first longitudinal natural history study provide insights into disease progression. GNAO1 ‐RD generally follows a non‐degenerative course, showing stability or mild improvements over time in cognition, language, adaptive skills, and motor function. Importantly, although global severity scores remained stable overall, severe cases showed cumulative functional burden driven by progressive movement disorder, rather than global neurodegeneration. Mortality occurred in a subset of patients because of complications from dyskinetic crises, infections, and epilepsy‐related events. Genotype–phenotype data and the GNAO1 ‐RD severity score support early risk stratification and personalized treatment development. ANN NEUROL 2026;100:154–170

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GTP-Binding Protein alpha Subunits, Gi-GoEpilepsyMovement DisordersNeurodevelopmental DisordersLongitudinal StudiesPhenotypeDisease ProgressionCross-Sectional StudiesSeverity of Illness IndexGenetic Association StudiesProspective StudiesRetrospective StudiesBiomarkersMagnetic Resonance ImagingHumansMaleFemaleChild, PreschoolChildAdolescentYoung Adult

Substanzen

GNAO1 protein, humanGTP-Binding Protein alpha Subunits, Gi-GoBiomarkers

Autor:innen und Institutionen

  • Epilepsy Unit, Department of Child Neurology, Coordinating member of the ERN EpiCARE, Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain.
  • Department of Rehabilitation, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Statistical Advising Service, Fundació de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
  • Pediatric Neurology Department, Hospital Sant Joan de Déu, Full Member of ERN EpiCare, Barcelona University, Barcelona, Spain.
  • Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
  • The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, University of Florida, Jupiter, FL, USA.

ORCID-Profile: Jana Domínguez-Carral, Kathryn Yang, Katerina Bernardi, Ainara Salazar-Villacorta, Beatriz De la Casa-Fages, Brahim Tabarki, Adolfo Alberto Gallo, Fabian Maass, Elizabeth Jennions, Jorge Luis Ramón-Gómez, Jennifer Friedman, Iván Espinoza-Quinteros, Monica Troncoso, Divyani Garg, Anna Duat-Rodriguez, Luca Soliani, Manju A Kurian, Siddharth Srivastava, Darius Ebrahimi-Fakhari, Kirill A Martemyanov, Juan Darío Ortigoza-Escobar

Förderung

  • NINDS NIH HHS

Zitieren

APA

Domínguez-Carral, J., Domínguez Cobo, A. M., Balsells, S., Aguilar-Ros, A., Chang, C. T., Ludlam, W. G., Yang, K., Bernardi, K., Chinigioli, M., Salazar-Villacorta, A., Di Pisa, V., Lamagrande-Casanova, N., González-Alguacil, E., De la Casa-Fages, B., Okumura, A., Rodríguez, J., Agarwal, A., Muñoz-Chesta, D., Reynoso-Osnayo, C., …, & Ortigoza-Escobar, J. D. (2026). Longitudinal Phenotypic Trajectories in GNAO1 ‐Related Disorders: Defining Disease Progression and Clinical Profiles. Annals of Neurology. https://doi.org/10.1002/ana.78213

Vancouver

Domínguez-Carral J, Domínguez Cobo AM, Balsells S, Aguilar-Ros A, Chang CT, Ludlam WG, et al. Longitudinal Phenotypic Trajectories in GNAO1 ‐Related Disorders: Defining Disease Progression and Clinical Profiles. Annals of Neurology. 2026. doi:10.1002/ana.78213

BibTeX
@article{DomnguezCarral2026,
  author = {Domínguez-Carral, Jana and Domínguez Cobo, Ana María and Balsells, Sol and Aguilar-Ros, Anna and Chang, Chu-Ting and Ludlam, William G and Yang, Kathryn and Bernardi, Katerina and Chinigioli, Micaela and Salazar-Villacorta, Ainara and Di Pisa, Veronica and Lamagrande-Casanova, Nuria and González-Alguacil, Elena and De la Casa-Fages, Beatriz and Okumura, Akihisa and Rodríguez, Josefina and Agarwal, Ayush and Muñoz-Chesta, Daniela and Reynoso-Osnayo, Carolina and Lin, Amy and Tabarki, Brahim and Parvin, Jobaida and Gallo, Adolfo Alberto and Forno, Andreia and Maass, Fabian and Montiel Blanco, Johnny and Nasif, Salomé and Jennions, Elizabeth and Ramón-Gómez, Jorge Luis and Verhelst, Helene and Nieto Barceló, Juan José and Čokolić Petrović, Dunja and García Ruiz, Luz Victoria and van Riesen, Christoph and Rego Sousa, Paulo and Massaro Sanchez, Maria Del Pilar and Khan, Husnea Ara and Hakami, Wejdan and Friedman, Jennifer and Espinoza-Quinteros, Iván and Troncoso, Monica and Garg, Divyani and Pauni, Micaela and Kurahashi, Hirokazu and Miranda-Herrero, María Concepción and Duat-Rodriguez, Anna and Soliani, Luca and Kurian, Manju A and Schteinschnaider, Angeles and Srivastava, Siddharth and Ebrahimi-Fakhari, Darius and Martemyanov, Kirill A and Ortigoza-Escobar, Juan Darío},
  title = {Longitudinal Phenotypic Trajectories in GNAO1 ‐Related Disorders: Defining Disease Progression and Clinical Profiles},
  journal = {Annals of Neurology},
  year = {2026},
  doi = {10.1002/ana.78213}
}
Kostenlos starten →